GKWIM
PACB icon

Gerber Kawasaki Wealth & Investment Management’s Pacific Biosciences PACB Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$1K – 839
2021
Q3 		$1K Buy
+1
New +$30 ﹤0.01% 1067

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's PACB Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Pacific Biosciences (PACB) in Q4 2021, closing a stake of 1 share — an estimated $1K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in PACB in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 256 funds tracked by Wall St. Rank hold PACB as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Pacific Biosciences position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 1 Pacific Biosciences share in Q4 2021, an estimated $1K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Pacific Biosciences in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Pacific Biosciences position peaked at $1K in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.